1104P Early time-point 18F-FDG-PET/CT at week four (W4) as a prognostic biomarker of survival in metastatic melanoma (mM) patients (pts) on immunotherapy.

Autor:	Hribernik, N.1 (AUTHOR), Strasek, K.2 (AUTHOR), Studen, A.2 (AUTHOR), Zevnik, K.3 (AUTHOR), Škalič, K.3 (AUTHOR), Jeraj, R.4 (AUTHOR), Rebersek, M.1 (AUTHOR)
Zdroj:	Annals of Oncology. 2024 Supplement 2, Vol. 35, pS731-S732. 2p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu